Comprehensive proteomic analysis of mesenchymal stem cell exosomes reveals modulation of angiogenesis via nuclear factor-kappaB signaling

Stem Cells

Volumn 34, Issue 3, 2016, Pages 601-613

  Anderson, Johnathon D ^a   Johansson, Henrik J ^b   Graham, Calvin S ^a   Vesterlund, Mattias ^b   Pham, Missy T ^a   Bramlett, Charles S ^a   Montgomery, Elizabeth N ^a   Mellema, Matt S ^c   Bardini, Renee L ^a   Contreras, Zelenia ^a   Hoon, Madeline ^a   Bauer, Gerhard ^a   Fink, Kyle D ^a   Fury, Brian ^a   Hendrix, Kyle J ^a   Chedin, Frederic ^d   El Andaloussi, Samir ^d,e   Hwang, Billie ^f   Mulligan, Michael S ^f   Lehtiö, Janne ^b   Nolta, Jan A ^a   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Exosomes; High resolution isoelectric focusing; Liquid chromatography tandem mass spectrometry; Mesenchymal stem cells; Nuclear factor kappaB; Peripheral arterial disease; Proteomics

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLATELET DERIVED GROWTH FACTOR; PROTEOME;

ADULT; ANGIOGENESIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; EXOSOME; HUMAN; HUMAN CELL; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; MALE; MESENCHYMAL STEM CELL; MICROENVIRONMENT; PARACRINE SIGNALING; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; YOUNG ADULT; BONE MARROW CELL; GENE EXPRESSION REGULATION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM;

BONE MARROW CELLS; EXOSOMES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; NF-KAPPA B; PARACRINE COMMUNICATION; PROTEOME; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84975745595     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.2298     Document Type: Article

References (60)

1. Milani RV, Lavie CJ,. The role of exercise training in peripheral arterial disease. Vasc Med 2007; 12: 351-358.
2. Katz G, Harchandani B, Shah B,. Drug-eluting stents: The past, present, and future. Curr Atherosclerosis Rep 2015; 17: 485.
3. Banfi A, von Degenfeld G, Gianni-Barrera R, et al., Therapeutic angiogenesis due to balanced single-vector delivery of VEGF and PDGF-BB. FASEB J 2012; 26: 2486-2497.
4. Yla-Herttuala S, Rissanen TT, Vajanto I, et al., Vascular endothelial growth factors: Biology and current status of clinical applications in cardiovascular medicine. J Am Coll Cardiol 2007; 49: 1015-1026.
5. Meyerrose T, Olson S, Pontow S, et al., Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors. Adv Drug Deliv Rev 2010; 62: 1167-1174.
6. Liew A, O'Brien T,. Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia. Stem Cell Res Ther 2012; 3: 28.
7. S ELA, Mager I, Breakefield XO, Wood MJ,. Extracellular vesicles: Biology and emerging therapeutic opportunities. Nat Rev Drug Discov 2013; 12: 347-357.
8. Bian S, Zhang L, Duan L, et al., Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. J Mol Med 2014; 92: 387-397.
9. Kordelas L, Rebmann V, Ludwig AK, et al., MSC-derived exosomes: A novel tool to treat therapy-refractory graft-versus-host disease. Leukemia 2014; 28: 970-973.
10. Zhang B, Wang M, Gong A, et al., HucMSC-exosome mediated -Wnt4 signaling is required for cutaneous wound healing. Stem Cells 2015; 33: 2158-2168.
11. Rosova I, Dao M, Capoccia B, et al., Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 2008; 26: 2173-2182.
12. Ikebe C, Suzuki K,. Mesenchymal stem cells for regenerative therapy: Optimization of cell preparation protocols. BioMed Res Int 2014; 2014: 951512.
13. Banfi A, von Degenfeld G, Blau HM,. Critical role of microenvironmental factors in angiogenesis. Curr Atheroscler Rep 2005; 7: 227-234.
14. Humar R, Kiefer FN, Berns H, et al., Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling. FASEB J 2002; 16: 771-780.
15. Yamakawa M, Liu LX, Date T, et al., Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing g multiple angiogenic factors. Circ Res 2003; 93: 664-673.
16. Beegle J, Lakatos K, Kalomoiris S, et al., Hypoxic preconditioning of mesenchymal stromal cells induces metabolic changes, enhances survival and promotes cell retention in vivo. Stem Cells 2015.
17. Johansson HJ, Sanchez BC, Mundt F, et al., Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer. Nat Commun 2013; 4: 2175.
18. Hultin-Rosenberg L, Forshed J, Branca RM, et al., Defining, comparing, and improving iTRAQ quantification in mass spectrometry proteomics data. Mol Cell Proteomics 2013; 12: 2021-2031.
19. Branca RM, Orre LM, Johansson HJ, et al., HiRIEF LC-MS enables deep proteome coverage and unbiased proteogenomics. Nat Methods 2014; 11: 59-62.
20. Witwer KW, Buzas EI, Bemis LT, et al., Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles 2013; 2.
21. Wisniewski JR, Zougman A, Nagaraj N, et al., Universal sample preparation method for proteome analysis. Nat Methods 2009; 6: 359-362.
22. Lai JC, Behar KL,. Glycolysis-citric acid cycle interrelation: A new approach and some insights in cellular and subcellular compartmentation. Dev Neurosci 1993; 15: 181-193.
23. Hayes JD, Dinkova-Kostova AT,. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem Sci 2014; 39: 199-218.
24. Saito R, Smoot ME, Ono K, et al., A travel guide to Cytoscape plugins. Nat Methods 2012; 9: 1069-1076.
25. Duffy GP, Ahsan T, O'Brien T, et al., Bone marrow-derived mesenchymal stem cells promote angiogenic processes in a time- and dose-dependent manner in vitro. Tissue Eng Part A 2009; 15: 2459-2470.
26. Iwase H, Wiegel B, Fehrenbacher G, et al., Comparison between calculation and measured data on secondary neutron energy spectra by heavy ion reactions from different thick targets. Radiat Prot Dosimetry 2005; 116 (pt 2): 640-646.
27. Kwon HM, Hur SM, Park KY, et al., Multiple paracrine factors secreted by mesenchymal stem cells contribute to angiogenesis. Vasc Pharmacol 2014; 63: 19-28.
28. Chu LH, Rivera CG, Popel AS, et al., Constructing the angiome: A global angiogenesis protein interaction network. Physiol Genom 2012; 44: 915-924.
29. Cline MS, Smoot M, Cerami E, et al., Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2007; 2: 2366-2382.
30. Mi H, Muruganujan A, Casagrande JT, et al., Large-scale gene function analysis with the PANTHER classification system. Nat Protoc 2013; 8: 1551-1566.
31. Soccio RE, Breslow JL,. Intracellular cholesterol transport. Arterioscler Thromb Vasc Biol 2004; 24: 1150-1160.
32. Lev S,. Nonvesicular lipid transfer from the endoplasmic reticulum. Cold Spring Harb Perspect Biol 2012; 4.
33. Baenke F, Peck B, Miess H, et al., Hooked on fat: The role of lipid synthesis in cancer metabolism and tumour development. Dis Model Mech 2013; 6: 1353-1363.
34. Zhang HC, Liu XB, Huang S, et al., Microvesicles derived from human umbilical cord mesenchymal stem cells stimulated by hypoxia promote angiogenesis both in vitro and in vivo. Stem Cells Dev 2012; 21: 3289-3297.
35. Simpson RJ, Kalra H, Mathivanan S,. ExoCarta as a resource for exosomal research. J Extracellular Vesicles 2012; 1.
36. Mathivanan S, Fahner CJ, Reid GE, et al., ExoCarta 2012: Database of exosomal proteins, RNA and lipids. Nucleic Acids Res 2012; 40 (Database issue): D1241-D1244.
37. Mathivanan S, Simpson RJ,. ExoCarta: A compendium of exosomal proteins and RNA. Proteomics 2009; 9: 4997-5000.
38. Bindea G, Mlecnik B, Hackl H, et al., ClueGO: A Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 2009; 25: 1091-1093.
39. Jiang W, Makhlouf F, Schuirmann DJ, et al., A bioequivalence approach for generic narrow therapeutic index drugs: Evaluation of the reference-scaled approach and variability comparison criterion. AAPS J 2015; 17: 891-901.
40. Kim HS, Choi DY, Yun SJ, et al., Proteomic analysis of microvesicles derived from human mesenchymal stem cells. J Proteome Res 2012; 11: 839-849.
41. Mindaye ST, Ra M, Lo Surdo JL, et al., Global proteomic signature of undifferentiated human bone marrow stromal cells: Evidence for donor-to-donor proteome heterogeneity. Stem Cell Res 2013; 11: 793-805.
42. Mindaye ST, Ra M, Lo Surdo J, et al., Improved proteomic profiling of the cell surface of culture-expanded human bone marrow multipotent stromal cells. J Proteomics 2013; 78: 1-14.
43. Capoccia BJ, Robson DL, Levac KD, et al., Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activity. Blood 2009; 113: 5340-5351.
44. Beckermann BM, Kallifatidis G, Groth A, et al., VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br J Cancer 2008; 99: 622-631.
45. Deuse T, Peter C, Fedak PW, et al., Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction. Circulation 2009; 120 (Suppl): S247-S254.
46. Fierro FA, Kalomoiris S, Sondergaard CS, et al., Effects on proliferation and differentiation of multipotent bone marrow stromal cells engineered to express growth factors for combined cell and gene therapy. Stem Cells 2011; 29: 1727-1737.
47. Ding W, Knox TR, Tschumper RC, et al., Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: Implications for an angiogenic switch. Blood 2010; 116: 2984-2993.
48. Gianni-Barrera R, Bartolomeo M, Vollmar B, et al., Split for the cure: VEGF, PDGF-BB and intussusception in therapeutic angiogenesis. Biochem Soc Trans 2014; 42: 1637-1642.
49. Tabernero J,. The role of VEGF and EGFR inhibition: Implications for combining anti-VEGF and anti-EGFR agents. Mol Cancer Res 2007; 5: 203-220.
50. Fujioka S, Sclabas GM, Schmidt C, et al., Function of nuclear factor kappaB in pancreatic cancer metastasis. Clin Cancer Res 2003; 9: 346-354.
51. Hou Y, Li F, Karin M, et al., Analysis of the IKKbeta/NF-kappaB signaling pathway during embryonic angiogenesis. Dev Dyn 2008; 237: 2926-2935.
52. Bronckaers A, Hilkens P, Martens W, et al., Mesenchymal stem/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis. Pharmacol Ther 2014; 143: 181-196.
53. Lai RC, Arslan F, Lee MM, et al., Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 2010; 4: 214-222.
54. Tan SS, Yin Y, Lee T, et al., Therapeutic MSC exosomes are derived from lipid raft microdomains in the plasma membrane. J Extracell Vesicles 2013; 2.
55. Masson N, Ratcliffe PJ,. Hypoxia signaling pathways in cancer metabolism: The importance of co-selecting interconnected physiological pathways. Cancer Metab 2014; 2: 3.
56. Li T, Yan Y, Wang B, et al., Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev 2013; 22: 845-854.
57. Katsuda T, Tsuchiya R, Kosaka N, et al., Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes. Sci Rep 2013; 3: 1197.
58. Lin SS, Zhu B, Guo ZK, et al., Bone marrow mesenchymal stem cell-derived microvesicles protect rat pheochromocytoma PC12 cells from glutamate-induced injury via a PI3K/Akt dependent pathway. Neurochem Res 2014; 39: 922-931.
59. Bruno S, Grange C, Deregibus MC, et al., Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 2009; 20: 1053-1067.
60. Xin H, Li Y, Liu Z, et al., MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells 2013; 31: 2737-2746.